Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Клинические результаты эндоваскулярной реваскуляризации в госпитальном периоде инфаркта миокарда без Q-зубца с использованием стентов с лекарственным покрытием
Клинические результаты эндоваскулярной реваскуляризации в госпитальном периоде инфаркта миокарда без Q-зубца с использованием стентов с лекарственным покрытием
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Kao W, Khaja F, Goldstein S. Cardiac event rate after non-Q-wave acute myocardial infarction and the significance of its anterior location. Am J Cardiol 1989; 64: 1236–42.
2. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989; 320:618: 627.
3. Early invasive versus conservative strategy in non-Q-MI. VANQWISH TRIAL. N Engl Med 1998; 338: 1785–92.
4. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology. Ryan TJ, Faxon DD, Gunnar RM. J Am Coll Cardiol 1988; 12: 529.
5. Matetzky S, Barabash GI, Rabinowitz B. Q-wave and non-Q-wave myocardial infarction after thrombolysis. J Am Coll Cardiol 1995; 26: 1445–51.
6. Yan AT, Tan M. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 2005; 95: 438.
7. Early invasive versus conservative strategy for acute coronary syndroms. TACTICS-TIMI 18. N Engl J Med 2001; 344: 1879–87.
8. Early invasive versus conservative strategy in unstable angina and non-Q-MI. FRISC I study. Lancet 1999; 354: 708–15.
9. Early invasive versus conservative strategy in unstable angina and non-Q-MI. FRISC II 1 year study. Lancet 2000; 356: 9–16.
10. Early invasive versus conservative strategy in non-ST elevation MI. MITI registry. J Am Coll Cardiol 2000; 35: 895–902.
11. Madsen S. et al. Invasive versus conservative strategy for ischemia after acute MI. DANAMI trial. Circulation 1997; 96: 748–55.
12. Colombo A, Fajadet J, Schuler G. 365-day follow-up of the RAVEL study: a randomized study with sirolimus-eluting BX Velocity balloon-expandable stent. Eur Heart J 2002; 4 (Suppl. A): 264.
13. Morice M-C, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standart stent for coronary revascularization. N Engl J Med 2002; 346: 1773–80.
14. Ivanhoe RJ et al. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis and long-term clinical follow-up. Circulation 1992; 85: 106–15.
15. Bell MR et al. Initial and long-term outcome of 354 patients after coronary balloon angioplasty of total coronary occlusion. Circulation 1992; 85: 1003–11.
16. Olivari Z et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions J Am Coll Cardiol 2003; 41: 1672–8.
17. Sirnes PA, Golf S, Myreng Y. Stenting in Chronic Coronary Occlusion (SICCO): a randomized controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996; 28: 1444–51.
18. Rubartelli P, Niccoli L, Verna E et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOS trial. J Am Coll Cardiol 1998; 32: 90–6.
19. Suero JA, Marso SP, Jones PG et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience. J Am Coll Cardiol 2001; 38: 409–14.
2. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989; 320:618: 627.
3. Early invasive versus conservative strategy in non-Q-MI. VANQWISH TRIAL. N Engl Med 1998; 338: 1785–92.
4. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology. Ryan TJ, Faxon DD, Gunnar RM. J Am Coll Cardiol 1988; 12: 529.
5. Matetzky S, Barabash GI, Rabinowitz B. Q-wave and non-Q-wave myocardial infarction after thrombolysis. J Am Coll Cardiol 1995; 26: 1445–51.
6. Yan AT, Tan M. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 2005; 95: 438.
7. Early invasive versus conservative strategy for acute coronary syndroms. TACTICS-TIMI 18. N Engl J Med 2001; 344: 1879–87.
8. Early invasive versus conservative strategy in unstable angina and non-Q-MI. FRISC I study. Lancet 1999; 354: 708–15.
9. Early invasive versus conservative strategy in unstable angina and non-Q-MI. FRISC II 1 year study. Lancet 2000; 356: 9–16.
10. Early invasive versus conservative strategy in non-ST elevation MI. MITI registry. J Am Coll Cardiol 2000; 35: 895–902.
11. Madsen S. et al. Invasive versus conservative strategy for ischemia after acute MI. DANAMI trial. Circulation 1997; 96: 748–55.
12. Colombo A, Fajadet J, Schuler G. 365-day follow-up of the RAVEL study: a randomized study with sirolimus-eluting BX Velocity balloon-expandable stent. Eur Heart J 2002; 4 (Suppl. A): 264.
13. Morice M-C, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standart stent for coronary revascularization. N Engl J Med 2002; 346: 1773–80.
14. Ivanhoe RJ et al. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis and long-term clinical follow-up. Circulation 1992; 85: 106–15.
15. Bell MR et al. Initial and long-term outcome of 354 patients after coronary balloon angioplasty of total coronary occlusion. Circulation 1992; 85: 1003–11.
16. Olivari Z et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions J Am Coll Cardiol 2003; 41: 1672–8.
17. Sirnes PA, Golf S, Myreng Y. Stenting in Chronic Coronary Occlusion (SICCO): a randomized controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996; 28: 1444–51.
18. Rubartelli P, Niccoli L, Verna E et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOS trial. J Am Coll Cardiol 1998; 32: 90–6.
19. Suero JA, Marso SP, Jones PG et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience. J Am Coll Cardiol 2001; 38: 409–14.
Авторы
А.П.Савченко1, П.А.Болотов2, О.В.Черкавская1, Б.А.Руденко1
1 Институт клинической кардиологии им. А.Л.Мясникова РКНПК Минздравсоцразвития РФ;
2 Центральный клинический военный госпиталь ФСБ РФ
1 Институт клинической кардиологии им. А.Л.Мясникова РКНПК Минздравсоцразвития РФ;
2 Центральный клинический военный госпиталь ФСБ РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.